MultiVir, Inc. (Multivir)

Oncology Corporate Profile

HQ Location

410 Pierce Street
Suite 325
Houston, TX 77002

Company Description

MultiVir is developing novel tumor suppressor and immune gene therapies based upon multiple viral delivery platforms. Our product candidates employ genetically engineered adenoviruses, herpes viruses and vaccinia viruses to deliver therapeutic genes into tumors.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
AD-IL 24interlukon adenoviralHead & Neck cancerII
AD-p53adenoviralColorectal cancerI
AD-p53adenoviralHepatocellular carcinoma (HCC)I
AD-VirRX 007adenoviralVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display